AI Verdict
CME has stronger fundamentals based on our AI analysis.
CME vs JPM Fundamental Comparison
| Metric | CME | JPM |
|---|---|---|
| Revenue | $6.5B | $182.4B |
| Net Income | $4.1B | $57.0B |
| Net Margin | 62.5% | 31.3% |
| ROE | 14.2% | 15.7% |
| ROA | 2.1% | 1.3% |
| Current Ratio | 1.03x | N/A |
| Debt/Equity | 0.00x | 0.74x |
| EPS | $11.16 | $20.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CME vs JPM: Frequently Asked Questions
Is CME or JPM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CME has stronger fundamentals. CME is rated BUY (86% confidence) while JPM is rated BUY (71% confidence). This is not investment advice.
How does CME compare to JPM fundamentally?
CME GROUP INC. has ROE of 14.2% vs JPMORGAN CHASE & CO's 15.7%. Net margins are 62.5% vs 31.3% respectively.
Which stock pays higher dividends, CME or JPM?
CME has a dividend yield of N/A or no dividend while JPM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CME or JPM for long term?
For long-term investing, consider that CME has BUY rating with 86% confidence, while JPM has BUY rating with 71% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CME vs JPM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CME vs JPM, the AI consensus favors CME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.